Skip to search formSkip to main contentSkip to account menu

Extensively Drug Resistance Process

Known as: EXTENSIVE DRUG RESISTANCE, XDR 
Resistance to nearly all known drugs, particularly the most efficacious or non-first line drugs, used in the treatment of a particular disease.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background We investigated the integron types and their relation with antibiotic resistance among A. baumannii isolates collected… 
Highly Cited
2014
Highly Cited
2014
Abstract Background: Colistin (COL) has become the backbone of the treatment of infections due to extensively drug-resistant (XDR… 
2013
2013
OBJECTIVES The development and transmission of extensively drug-resistant (XDR) tuberculosis (TB) constitutes a serious threat to… 
Highly Cited
2012
Highly Cited
2012
The first complete submillimeter spectrum (190–670 μm) of the Seyfert 2 galaxy NGC 1068 has been observed with the SPIRE Fourier… 
2012
2012
Objective: The aim of this study was to evaluate several polymer carriers with regard to the bioavailability enhancement of… 
Highly Cited
2011
Highly Cited
2011
Objective Extreme drug-resistant Pseudomonas aeruginosa (XDR-PA) with decreased susceptibility to polymyxin B (PB) has emerged in… 
2011
2011
New drugs are desperately needed to combat XDR-TB as effective treatment involves at least four drugs to which the patient is… 
2009
2009
The rising number of multi-drug resistant tuberculosis (MDR-TB) cases worldwide prompted the World Health Organisation (WHO) to…